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ABSTRACT
Objectives: The aim of this study is to investigate anti-inflammatory activity of β-glucan (laminaran) of brown algae, Sargassum crassifolium which 
was extracted by using two different methods, β-glucan laminaran acid extract (LAE) and laminaran modified extract (LME).
Methods: β-glucan (laminaran) of brown algae, S. crassifolium have been extracted using two different methods, namely, β-glucan LAE and LME. The 
edema reducing activity of the extracts was investigated with carrageenan- induced leg edema male of Rattus norvegicus as a model.
Results: The swelling of edema was strongly inhibited by the treatment of LME with a percentage of 81.62% after 3rd hr. It also found that the size 
of edema were inhibited by all treatments with the value ranging from 25.49% to 81.68%. Smallest edema size was found on LME treatment, with a 
size of 0.68±0.09 mm where the control was about 0.92 mm. Furthermore, all β-glucan-treated mice showed lower edema size compared to control.
Conclusion: It was obvious that all type of laminaran had anti-inflammatory activity. LME is the best method for production of β-glucan (laminaran) 
with high anti-inflammatory activity. Hence, in this study, we reported a new anti-inflammatory agent derived from S. crassifolium.
Keywords: β-glucan (laminaran), Edema, Sargassum crassifolium, Carrageenan, Edema.
INTRODUCTION
Exploration of marine natural resources have been attracting 
scientist attention. Many resources, such algae, microorganism, 
wait to be explored [1,2]. One of the potential algae is brown algae, 
Sargassum sp. Sargassum grouped in order of Fucales. Many species 
are distributed over tropical regions, including Indonesia. This algae 
is a source of β-glucan (laminaran), linear polysaccharide composed of 
β-(1,3) -linked glucose in its main chain, with β - (1, 6) -linked -chain 
branch differed depending on the variant of the isolated species, as well 
as the predicted environmental factors directly affect the biological 
properties [3,4]. By far, exploration of brown algae Sargassum sp. 
for its uses as anti-inflammatory, anti-infective, antimicrobial, anti-
cholesterol, antioxidant, antitumor, and antiaging agents has attract 
many marine biologist as well as marine biotechnologist [5,6].
Inflammation is a local response of living mammals’ injured tissue. 
It is a defense reaction of the body to eliminate or limit the spread of 
harmful agents [7]. Complex occurrences and mediators involved in the 
inflammatory reaction could cause or worsen [8] the condition. There 
are various components to inflammatory reactions contributing to the 
symptoms associated with tissue injury. Edema, leukocyte infiltration, 
and granuloma formations are components representing inflammatory 
condition [9].
In this study, we investigate the potency of β-glucan (laminaran) 
derived from brown algae, Sargassum crassifolium for anti-inflamatory 
agent through edema reducing activity.
METHODS
Materials and equipment
Materials used in this study were S. crassifolium. They harvested 
from Talango Island, Madura, Indonesia. All chemicals agents such λ 
carrageenan, phenyl butazone (Sigma Aldrich, USA), and ethylphenyl 
propiolate (EPP) (Fluka, Japan) including other materials such as 
rivanol and alcohol 70% are analytical grades.
Preparation of β-glukan (laminaran) extract
The brown alga, S. crassifolium, was sun dried. The samples chopped 
into pieces and then filtered to obtain powder. Algae was extracted 
using Yvin et al. and Mohan et al. [10,11] method with modification. 
Using two different extraction tools, the hot plate magnetic stirrer 
(HPMS) and ultra-sonication. β-glucan (laminaran) generated from 
HPMS with sulfuric acid as a solution called laminaran acid extract 
(LAE). For the result of the ultrasonic method with distilled water as 
solution, the extract called laminaran modified extract (LME).
Test animal
40 male rat (20 for paw edema and 20 Wistar rats for ear edema 
experiments) with the weight of 180-200 g used as test animals. 
Each of them placed in individual cages. The wistar rat kept under 
standard environmental conditions and had free access to diet and 
water (ad libitum). All of these animals acclimatized for a week before 
testing period. All experimental procedures conducted by following the 
guidelines of Brawijaya University Animal Ethics Committee.
Anti-inflammatory activity test with carrageenan hind paw edema
20 rat divided into 4 groups, each of 5 wistar rat, treated with the 
administered extracts a similar concentration of 375 mg/sample, while a 
control was left without treatment. Edema was induced by 100 uL subplantar 
injection containing 1% solution of carrageenan suspended in fresh 0.9% 
NaCl solution. The solution injected into the subplantar tissue of the right 
rear leg of Wistar rat. Linear foot circumference measured at intervals of 
1, 3, and 5 hrs. Anti-inflammatory activity measured as the percentage 
reduction of edema relative to controls after topical medications [12].
Mouse ear swelling assays (MESA) with EPP
The ear swelling test conducted using a method modified from 
Frenkel [13], in which the ears of wistar rat subcutaneously injected 
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with EPP for hypersensitivity test Nualkaew et al. [14]. Suggested that 
that before the use of EPP, ear of test animals should be measured in 
advance using a caliper. EPP was used as inflammatory agent, which 
was injected subcutaneously at a dose of 1 mg/20 uL/ear. LAE and LME 
extracts were individually dissolved in 5% dimethyl sulfoxide in acetone 
at a concentration of 375 mg/ml in a similar volume of 0.5 ml/100 g of 
animal weight, which was then administered topically to the surface of the 
inner and outer ear. Results of observation showed that the highpoint of 
swelling was 4 hrs after induction. Ear thickness was measured. Effects of 
β-glucan extract (laminaran) on ear edema in both control and treatment 
groups were compared, and the percentage inhibition was then calculated.
RESULTS AND DISCUSSION
Carrageenan-induced paw edema
Edema of hind paw induced by carrageenan has been extensively used 
as a model of inflammation in the search for new anti-inflammatory 
drugs. Edema-reducing activity was evaluated using a method, which 
is based on rat leg edema induced by carrageenan, modified from 
Winter et al. and Adeyemi et al. [15,16]. The results of this work were 
presented in Table 1.
After the carrageenan induction, wistar rat got leg swelling at the 
first 1 hr, in both control and treatment groups. In control group, 
increased swelling in control group occurred during early 5 hrs of 
observation. Whereas in all treatment groups, which rat were treated 
with β-glucan (laminaran) extracts (LAE, LME), inhibition similarly 
occurred and peaked at the 3rd hr. Ratheesh and Helen [17] reported 
that study on Ruta graveolens as an anti-inflammatory also showed 
maximum inhibition of inflammation after 3rd hrs of observation. This 
is corroborated by a report from Adeyemi et al. [16] which stated that 
the effects of P. americana extracts on carrageenan-induced edema legs 
are most prominent in the 3rd hrs. Amdekar et al. [9] demonstrated a 
slight difference result in the maximum time triggering inflammation, 
i.e., at 4th hrs, when researching the inhibition effects on inflammation 
by Lactobacillus casei and L. acidophilus.
The mechanism of edema production of by carrageenan is possibility 
due to release of prostaglandins (PG), which is in line with the 
release phase of prostaglandin at the 3rd hrs [18]. The development 
of inflammation or edema in the legs of Wistar rat after injection of 
carrageenan is due to the release of histamine, serotonin, and PG [17].
LME extract significantly suppressed the Wistar rat feet edema by 81.62%, 
followed by LAE extract, and LMEs by 73.47% and 67.35%, respectively. 
This means that LME extract can function as an anti-inflammatory 
compound and even with the strongest activity as observed in this study. 
When compared to results of Ratheesh and Helen [17] using R. graveolens 
as object of the study, and the introduction of 20 mg/kg dose, results 
in this study demonstrated that the decrease of mice edema by 90.9% 
inhibition was still lower than ability of extracts LME to do so. However, 
the decrease is higher when compared to the results from Voveran as 
standard drug (72.72%) [17]. This means that the anti-inflammatory 
activity of LME extracts is higher than that of Voyeran.
MESA
EPP is a material used to cause edema in addition to arachidonic acid. 
EPP was usually used on the ear of test animals such as mice. Non-
invasive swelling test of mouse ear (MESA) is a delayed hypersensitivity 
model type used as a promising testing protocol for allergic contact 
dermatitis (ACD). The formation of ear edema of mice induced by EPP 
is a model useful for screening and investigating the anti-inflammatory 
activity of the tested substance in the acute phase of inflammation [19]. 
MESA allows the identification of potential of ACD for β-glucan 
(laminaran) at very low concentrations of applications, which could not 
produce ACD using other techniques.
In this study, using EPP subcutaneously injected into the Wistar rat ears, 
it turns out the edema response occurred very slowly, where swelling 
detected just after 8 hrs as shown in Table 2.
The thickness of edema on both right and left ears of wistar rat in the 
control group on 8 hrs after the injection, reached the highest level 
(0.92±0:03 mm). LAE, LME extracts with better inhibition intensity 
better that using another commercial anti-inflammatory drug, 
phenylbutazone (at a dose of 1 mg/ear). The lowest thickness of rat ear 
edema obtained from treatment using LME extract by 0.71 mm ±0:09 
meaning that LME extracts generated significant inhibitory activity 
on edema formation at a dose of 375 mg/ml/ear, compared to 
other treatments did, also provided slightly higher intensity than 
phenylbutazone did. Thickness reduction of edema occurred on day 
12th of observation, on both the right and left ears of rat.
The occurrence of edema in the ear is caused by the release of 
inflammatory mediators such as histamine, serotonin, bradykinin, 
and PG. These mediators are able to promote vasodilation and to 
increase vascular permeability. Hence, it would synergistically produce 
edema [20]. It was known that the LME extract had inhibitory effect on 
edema formation. According Panthong et al. [19], the tested extract may 
possess anti inflammatory activity by inhibiting the release or synthesis 
of a variety of inflammatory mediators.
CONCLUSION
β-glucan (laminaran) LME extract exhibited edema-reducing activity 
which was proved by its inhibition against the right feet of carrageenan 
induced-edema with a percentage inhibition of 81.62% after 3 hrs 
treatment. It also inhibits the wistar rat ear swelling by 0.71 mm ±0:09, 
which was higher than that of control, phenyl butazon. Therefore, 
β-glucan (laminaran) from S. crassifolium able to act as edema-reducing 
agent.
ACKNOWLEDGMENT
The Authors Thanks to Ministry of Research, Technology and Higher 
Education of the Republic of Indonesia Throughout the Grant of the 
Research.
Table 1: Edema reducing activity of β-glucan (laminaran) on 
Edema-hind paw of Rattus norvegicus
Observation (hour) Sample Mean size of 
edema (cm)
Relative 
inhibition on 
control (%)
1 hr Control 0.38±0.025
LAE 0.27±0.13 28.95
LME 0.24±0.16 36.84
3 hrs Control 0.49±0.041
LAE 0.13±0.08 73.47
LME 0.09±0.08 81.62
5 hrs Control 0.51±0.041
LAE 0.38±0.13 25.49
LME 0.33±0.13 35.29
R. norvegicus: Rattus norvegicus, LAE: Laminaran acid extract, LME: Laminaran 
modified extract
Table 2: Edema reducing activity of β-Glucan (laminaran) on ear 
edema of Rattus norvegicus
Hour Control Edema value (mm, X±SD)
Phenyl 
butazon
LAE LME
Right ear
8 0.92±0.03 0.78±0.07 0.79±0.08 0.71±0.09
12 0.92±0.03 0.72±0.09 0.75±0.08 0.68±0.09
Left ear
8 0.93±0.055 0.81±0.12 0.79±0.05 0.74±0.07
12 0.93±0.055 0.69±0.14 0.76±0.04 0.72±0.08
R. norvegicus: Rattus norvegicus, LAE: Laminaran acid extract, 
LME: Laminaran-modified extract, SD: Standard deviation
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